Literature DB >> 25202694

Role of ischemic preconditioning in hepatic ischemia-reperfusion injury.

Valeriy V Boyko1, Margarita E Pisetska1, Oleksandr M Tyshchenko1, Denys I Skoryi1, Tatiana V Kozlova1, Natalia I Gorgol1, Igor V Volchenko1.   

Abstract

BACKGROUND: Investigation into less traumatic method of vascular occlusion during liver resection is the actual problem in hepatic surgery because of high level of complications such as liver failure. In this connection, the goal of our study was to determine the optimal model of vascular clamping. The research showed that vascular occlusion with ischemic preconditioning in the mode 5/10/15 the most delicate technique.
METHODS: Forty white giant rabbits were divided randomly into four groups (n=10 in each group). In group I we used continuous Pringle maneuver by 30 min. In group II we used intermittent Pringle maneuver: 15 min of clamping/5 min of unclamping (reperfusion)/15 min of clamping. In group III we used intermittent Pringle maneuver with ischemic precondition: 5 min of ischemia/5 min of reperfusion, 10 min of ischemia/5 min of reperfusion/15 min of ischemia. Group IV (control group) is without hepatic ischemia. All animals were performed a liver biopsy at the end of the surgery. Five rabbits from each group underwent re-laparotomy on day 3 after surgery with biopsy samples being taken for studying reparative processes in liver parenchyma.
RESULTS: Results of morphometric analysis were the best to illustrate different level of liver injury in the groups. Thus, there were 95.5% damaged hepatocytes after vascular occlusion in hepatic preparations in group I, 70.3% damaged hepatocytes in group II, and 42.3% damaged hepatocytes in group III. There were 5.3% damaged hepatocytes in the control group.
CONCLUSIONS: Vascular occlusion with ischemic preconditioning in the mode 5/10/15 the most delicate technique that does not involve major structural injuries and functional disorders in the remnant liver. Thus, it is amenable to translation into clinical practice and may improve outcomes in liver resection with inflow vascular occlusion.

Entities:  

Keywords:  Liver resection; Pringle maneuver; ischemia-reperfusion injury; ischemic preconditioning; vascular occlusion

Year:  2014        PMID: 25202694      PMCID: PMC4141290          DOI: 10.3978/j.issn.2304-3881.2014.06.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  8 in total

1.  Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans.

Authors:  P A Clavien; S Yadav; D Sindram; R C Bentley
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway.

Authors:  S S Yadav; D Sindram; D K Perry; P A Clavien
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

3.  Modulation of microcirculatory changes in the late phase of hepatic ischaemia-reperfusion injury by remote ischaemic preconditioning.

Authors:  Niteen Tapuria; Sameer Junnarkar; Mahmoud Abu-Amara; Barry Fuller; Alexander M Seifalian; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2011-11-27       Impact factor: 3.647

Review 4.  Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion.

Authors:  Mahmoud Abu-Amara; Kurinchi Gurusamy; Satoshi Hori; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

Review 5.  Methods of vascular control technique during liver resection: a comprehensive review.

Authors:  Wan-Yee Lau; Eric C H Lai; Stephanie H Y Lau
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-10

6.  Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study.

Authors:  Vassilios Smyrniotis; Kassiani Theodoraki; Nikolaos Arkadopoulos; Georgios Fragulidis; Agathi Condi-Pafiti; Matrona Plemenou-Fragou; Dionysios Voros; John Vassiliou; Panagiotis Dimakakos
Journal:  Am J Surg       Date:  2006-11       Impact factor: 2.565

7.  Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis.

Authors:  Shao-Qiang Li; Li-Jian Liang; Jie-Fu Huang; Zhi Li
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

Review 8.  Methods of vascular occlusion for elective liver resections.

Authors:  Kurinchi Selvan Gurusamy; Hemant Sheth; Yogesh Kumar; Dinesh Sharma; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  8 in total
  4 in total

Review 1.  How much ischemia can the liver tolerate during resection?

Authors:  Wouter G van Riel; Rowan F van Golen; Megan J Reiniers; Michal Heger; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

2.  Shock releases bile acid inducing platelet inhibition and fibrinolysis.

Authors:  Gregory Wiener; Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Scott Diamond; Shu Zhu; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

3.  Differential Effects of Three Techniques for Hepatic Vascular Exclusion during Resection for Liver Cirrhosis on Hepatic Ischemia-Reperfusion Injury in Rats.

Authors:  Changjun Jia; Chaoliu Dai; Hailiang Wang; Yi Wan; Yunyu Qiao; Feng Xu; Songlin Peng; Yang Zhao; Chuang Zhao; Liang Zhao
Journal:  Gastroenterol Res Pract       Date:  2018-01-08       Impact factor: 2.260

4.  Hepatoprotective effects of limb ischemic post-conditioning in hepatic ischemic rat model and liver cancer patients via PI3K/ERK pathways.

Authors:  Yanfeng Gao; Shuang Zhou; Fengfei Wang; Yue Zhou; Sen Sheng; Dan Qi; Jason H Huang; Erxi Wu; Yi Lv; Xiongwei Huo
Journal:  Int J Biol Sci       Date:  2018-11-03       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.